Equities

Sinocelltech Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Sinocelltech Group Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)39.38
  • Today's Change-0.63 / -1.57%
  • Shares traded2.03m
  • 1 Year change+4.76%
  • Beta1.4698
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Sinocelltech Group Ltd is a China-based company principally engaged in the research and development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and innovative vaccines. The Company's products include SCT800, SCT400, SCT630, SCT510, SCTV01 and others. The Company's products are mainly used in multiple treatment and prevention fields such as malignant tumors, autoimmune diseases, infectious diseases and genetic diseases. The Company mainly operates its businesses in the domestic market.

  • Revenue in CNY (TTM)1.89bn
  • Net income in CNY-310.15m
  • Incorporated2007
  • Employees2.28k
  • Location
    Sinocelltech Group LtdBlock 5, No. 31 Kechuang Qi StreetBeijing Economic and Technological DevelBEIJING 100176ChinaCHN
  • Phone+86 1 050812198
  • Fax+86 1 058628299
  • Websitehttps://www.sinocelltech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Medicilon Inc1.08bn-231.86m8.93bn2.27k--4.33--8.27-1.75-1.758.0415.360.37598.561.68459,338.00-8.083.66-9.994.6316.2731.15-21.496.672.19--0.150840.97-24.0118.22-896.21--2.54--
Bio-Thera Solutions Ltd845.32m-368.84m9.81bn1.17k--20.27--11.61-0.8908-0.89082.041.170.37020.77225.96---16.15-16.38-33.76-22.2274.9977.05-43.63-62.110.4617-34.120.573--5.44302.90-29.34--11.14--
HitGen Inc498.51m114.11m11.80bn483.00104.308.02--23.670.28240.28241.243.670.27266.374.691,032,114.006.183.066.873.3655.2353.5522.6714.485.126.590.167434.3214.9910.0826.13-15.653.16--
InventisBio Co Ltd180.53m-116.28m12.73bn185.00--7.64--70.51-0.2012-0.20120.31222.880.0988--1.03975,824.70-6.36-32.89-6.76-35.2299.41---64.41-682.73----0.0127---9.0225.0015.41---3.97--
Mabwell Shanghai Bioscience Co Ltd624.52m-947.49m14.55bn1.36k--19.12--23.30-2.37-2.371.561.900.13840.345814.57441,048.00-21.06-29.90-36.19-36.1888.7285.56-152.14-1,188.680.8093-10.820.7353--56.2846.680.9031--12.25--
Sinocelltech Group Ltd1.89bn-310.15m17.54bn2.28k------9.29-0.6964-0.69644.24-0.10830.54580.43253.04828,989.10-8.37-22.66-29.60-48.2593.5195.52-15.33-42.960.5008-0.67531.02--33.13294.24127.39--23.95--
BeBetter Med Inc-100.00bn-100.00bn19.08bn150.00--88.59----------0.4785----------------------------0.0116------67.59------
InnoCare Pharma Ltd1.43bn-229.64m23.19bn1.15k--6.41--16.25-0.1508-0.15080.88553.780.15041.703.741,245,225.00-2.52-6.41-2.87-7.4586.9786.07-16.78-71.716.44--0.1996--36.68281.6330.20--3.42--
Joinn Laboratories China Co Ltd1.67bn225.09m25.00bn2.65k105.903.33--14.990.34050.34052.3710.840.1750.78436.03629,011.802.366.602.727.9224.6341.8713.4725.983.06--0.003923.59-15.0725.85-81.34-16.8916.27-19.46
Dizal Pharmaceutical Co Ltd607.75m-867.44m25.02bn852.00--17.17--41.17-2.01-2.011.403.140.26440.81025.84713,322.50-37.97-46.55-55.30-56.2495.1290.63-143.64-825.752.42-111.090.4239--294.2454.4023.63--58.33--
Wuhan Healthgen Biotechnology Corp23.39m-160.81m25.75bn215.00--51.82--1,101.23-0.4498-0.44980.06541.39------131,386.80--------41.12---687.60--0.359-30.870.5497--3.92--19.04------
Data as of Feb 13 2026. Currency figures normalised to Sinocelltech Group Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

4.99%Per cent of shares held by top holders
HolderShares% Held
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20253.18m0.72%
ICBC UBS Asset Management Co. Ltd.as of 30 Jun 20253.11m0.70%
China Southern Asset Management Co., Ltd.as of 30 Jun 20252.93m0.66%
China Universal Asset Management Co., Ltd.as of 30 Jun 20252.48m0.56%
Yinhua Fund Management Co., Ltd.as of 30 Jun 20252.38m0.54%
China Asset Management Co., Ltd.as of 30 Jun 20252.14m0.48%
China Merchants Fund Management Co., Ltd.as of 31 Mar 20252.02m0.46%
Bosera Asset Management Co., Ltd.as of 30 Jun 20251.40m0.32%
Penghua Fund Management Co., Ltd.as of 30 Jun 20251.31m0.30%
Tian Hong Asset Management Co., Ltd.as of 30 Jun 20251.15m0.26%
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.